Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

<p>Abstract</p> <p>Background</p> <p>Stereotactic ablative radiotherapy (SABR) can achieve excellent local control rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard treatment option for patients who cannot undergo surgery or those wit...

Full description

Bibliographic Details
Main Authors: Chang Joe Y, Liu Hui, Balter Peter, Komaki Ritsuko, Liao Zhongxing, Welsh James, Mehran Reza J, Roth Jack A, Swisher Stephen G
Format: Article
Language:English
Published: BMC 2012-09-01
Series:Radiation Oncology
Subjects:
Stereotactic body radiotherapy
Stereotactic ablative radiotherapy
Non-small cell lung cancer
F-fluorodeoxyglucose positron emission tomography
Toxicity
Predictive factors
Online Access:http://www.ro-journal.com/content/7/1/152

Internet

http://www.ro-journal.com/content/7/1/152

Similar Items